New Key Statistics Module, Z-Score and F-Score
NAS:HRTX Key Ratios
| Market Cap $ M | 393.16 |
| Enterprise Value $ M | 492.38 |
| P/E(ttm) | -- |
| PE Ratio without NRI | -- |
| Forward PE Ratio | -- |
| Price/Book | -- |
| Price/Sales | 2.73 |
| Price/Free Cash Flow | -- |
| Price/Owner Earnings | -- |
| Payout Ratio % | -- |
| Revenue (TTM) $ M | 127.00 |
| EPS (TTM) $ | -0.84 |
| Beneish M-Score | -3.66 |
| 10-y EBITDA Growth Rate % | 10.40 |
| 5-y EBITDA Growth Rate % | 18.50 |
| y-y EBITDA Growth Rate % | -- |
| EV-to-EBIT | -4.62 |
| EV-to-EBITDA | -4.74 |
| PEG | -- |
| Shares Outstanding M | 150.64 |
| Net Margin (%) | -87.02 |
| Operating Margin % | -87.07 |
| Pre-tax Margin (%) | -87.02 |
| Quick Ratio | 1.84 |
| Current Ratio | 2.37 |
| ROA % (ttm) | -49.15 |
| ROE % (ttm) | -- |
| ROIC % (ttm) | -133.06 |
| Dividend Yield % | -- |
| Altman Z-Score | -11.55 |
HRTX Number of Guru Trades
HRTX Volume of Guru Trades
Gurus Latest Trades with NAS:HRTX
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
NAS:HRTX is held by these investors
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Heron Therapeutics Inc Insider Transactions
No Available Data
News about NAS:HRTX
Total 0- 1
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers